Most teens with gynecomastia don't need hormone lab tests

June 30, 2018, Wolters Kluwer Health

Routine assessment by an endocrinologist and laboratory tests to measure hormone levels aren't necessary in most adolescent boys with gynecomastia (male breast enlargement), concludes a study in the July issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

The cause of adolescent gynecomastia can usually be identified without endocrine testing, according to the study by Jugpal S. Arneja, MD, MBA, and colleagues of University of British Columbia, Vancouver, Canada. They propose an "evidence-based rationale for evaluation and workup" for the distressing problem of enlargement in adolescent males—including referral for male breast reduction surgery if the problem persists beyond age 16.

Lab Tests Contribute Little to Gynecomastia Diagnosis and Treatment in Teens

The researchers analyzed 197 adolescents with gynecomastia seen at British Columbia Children's Hospital from 1990 through 2015. Although adolescent gynecomastia is a common issue that usually resolves with time, it has been standard practice to send these teens for evaluation by an endocrinologist: a specialist in diseases of the glands and hormones.

Median age was 11.5 years when the developed gynecomastia and 14.2 years at their first endocrinology visit. About 70 percent of patients had psychological distress due to their breast enlargement. The study focused on the "utility and diagnostic yield" of routine endocrinology assessment and hormone laboratory testing.

Most patients had known risk factors for adolescent gynecomastia—especially obesity/overweight, present in about 50 percent of patients. Another 15 percent had a family history suggesting an increased risk of gynecomastia, such as the father having breast enlargement as an adolescent.

In only eight percent of patients, some "secondary" cause of gynecomastia was diagnosed. Most of these involved drugs linked to male breast enlargement, including marijuana, the antidepressant drug fluoxetine, or anti-seizure drugs used to treat epilepsy. Some patients had medical causes of breast enlargement—most commonly (three patients) the inherited chromosomal disorder Klinefelter syndrome.

Most patients underwent laboratory testing to measure levels of hormones, such as testosterone and estradiol (a form of estrogen). Importantly, these tests had abnormal results in just three patients: a rate of 1.7 percent. Dr. Arneja and colleagues write, "Endocrinological investigations did not yield new clinical information in 99.4 percent of cases."

Despite their low diagnostic value, these evaluations carried considerable costs. Based on ASPS data on for gynecomastia, a rough estimate of these costs was nearly $5 million for in 2016 alone. The authors note that unnecessary endocrinology referrals may carry an additional opportunity cost in Canada, where patients may face long waiting lists for specialist visits.

Overall, 51 percent of patients received no medical treatment, other than "watchful waiting" or diet and exercise to lose weight. In this group, gynecomastia resolved over time ( 14.6 years). Five percent of patients were treated with medications. The remaining patients, about 44 percent, underwent plastic surgery to treat their gynecomastia. Median age at surgery was 16.5 years.

Since breast enlargement often resolves with time, "reassurance and monitoring is the mainstay of early management," Dr. Arneja and coauthors write. They suggest that surgery be considered if gynecomastia has persisted for two years or beyond the age of 16, or for patients who are severely distressed.

Dr. Arneja and colleagues discuss the implications for evaluation and management of adolescents with gynecomastia. They highlight the importance of obtaining a thorough medical history—especially since most cases of secondary gynecomastia are medication-related. They conclude, "We do not suggest routine endocrinology workup, as it adds little value."

Explore further: Gynecomastia has psychological impact on adolescent boys

More information: Armaan K. Malhotra et al. Do Adolescents with Gynecomastia Require Routine Evaluation by Endocrinology?, Plastic and Reconstructive Surgery (2018). DOI: 10.1097/PRS.0000000000004465

Related Stories

Gynecomastia has psychological impact on adolescent boys

April 2, 2013
Persistent breast enlargement (gynecomastia) negatively affects self-esteem and other areas of mental and emotional health in in adolescent males, reports the April issue of Plastic and Reconstructive Surgery, the official ...

Good results with surgery for gynecomastia in bodybuilders

January 28, 2015
With attention to some unique patient characteristics, breast reduction surgery achieves good aesthetic outcomes in bodybuilders with gynecomastia—enlargement of the male breast, according to a report in the February issue ...

Reducing the side effects of treatment for prostate cancer

August 27, 2012
New research published in BioMed Central's open access journal BMC Medicine reassessing clinical data from trials, which investigate ways of treating side effects of therapy for prostate cancer, finds that tamoxifen, an anti-estrogen ...

Men turn to plastic surgeons for a better body image and more confidence at every age

June 13, 2018
Body image is an issue most commonly discussed among women, but new statistics released by the American Society of Plastic Surgeons reveal that it's a conversation that is emerging among men. More men are seeking help from ...

Young women at high genetic risk of breast cancer—plastic surgeons play key role in treatment

May 30, 2018
With available testing for breast cancer risk genes, some women are learning at young ages that they are at high lifetime risk of breast cancer. Plastic surgeons play a key role in counseling and managing this group of high-risk ...

Surgery benefits older women with breast cancer

May 23, 2018
In a BJS (British Journal of Surgery) analysis of 18,730 older patients with oestrogen receptor- positive breast cancer in the UK, the risk of dying from breast cancer was greater in patients treated with primary endocrine ...

Recommended for you

Surgeons have substantial impact on genetic testing in breast cancer patients who need it

July 3, 2018
For many women diagnosed with breast cancer, genetic testing can offer important information that might guide treatment choices. But studies have shown that only about half of women who could benefit receive genetic testing.

First major study comparing robotic to open surgery published in The Lancet

June 21, 2018
The first comprehensive study comparing the outcomes of robotic surgery to those of traditional open surgery in any organ has found that the surgeries are equally effective in treating bladder cancer. The seven-year study, ...

Antibodies may predict transplant rejection risk

June 19, 2018
The presence of certain antibodies in patients may suggest a higher risk of transplant rejection across multiple organ types, including the kidney, liver, heart and lungs, according to a new study published in PLOS Medicine.

First human test of robotic eye surgery a success

June 18, 2018
Researchers from the University of Oxford have completed the first successful trial of robot-assisted retinal surgery.

Surgical blood transfusions tied to clot risk

June 13, 2018
(HealthDay)—Blood transfusions around the time of surgery may raise your risk for dangerous blood clots, researchers say.

Tonsil and adenoid removal associated with respiratory, allergic and infectious disease

June 7, 2018
Tonsil and adenoid removal associated with long-term risks of respiratory, allergic and infectious diseases Removing tonsils and adenoids in childhood increases the long-term risk of respiratory, allergic and infectious diseases, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.